Effects of watercress consumption on urinary metabolites of nicotine in smokers

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 10, 1999, Pages 907-913

  Hecht, Stephen S ^a,b   Carmella, Steven G ^a   Murphy, Sharon E ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Box 806 Mayo ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CARCINOGEN; COTININE; CYTOCHROME P450; GLUCURONIDE; NICOTINE; NICOTINE DERIVATIVE; PHENETHYL ISOTHIOCYANATE; TOBACCO SMOKE;

ADULT; ARTICLE; CANCER PREVENTION; CHEMICAL STRUCTURE; CIGARETTE SMOKING; CLINICAL ARTICLE; DIETARY INTAKE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; URINALYSIS; VEGETABLE;

ADULT; ANTICARCINOGENIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; BIOTRANSFORMATION; COTININE; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; FOOD HABITS; GLUCURONOSYLTRANSFERASE; HUMANS; ISOTHIOCYANATES; MALE; MIXED FUNCTION OXYGENASES; NICOTINE; SMOKING; VEGETABLES;

EID: 0032735407     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Schultz, V. O-E., and Gmelin, R. Papierchromatographie der Senfölgucosid-Drogen. Z. Naturforschg, 7b: 500-506, 1952.
2. Fenwick, G. R., Heaney, R. K., and Mawson, R. Glucosinolates. In: Checke, P. R. (ed.). Toxicants of Plant Origin, Vol. II, pp. 2-41. Boca Raton, FL: CRC Press, Inc., 1989.
3. Tookey, H. L., VanEtten, C. H., and Daxenbichler, M. E. Glucosinolates. In: Liener, I. E. (ed.), Toxic Constituents of Plant Stuffs, pp. 103-114. New York: Academic Press, Inc., 1980.
4. Chung, F-L., Morse, M. A., Eklind, K. I., and Lewis, J. Quantitation of human uptake of the anticarcinogen phenethyl isothiocyanate after a watercress meal. Cancer Epidemiol., Biomarkers Prev., 1: 383-388, 1992.
5. Hecht, S. S., Chung, F-L., Richie, J. P., Jr., Akerkar, S. A., Borukhova, A., Skowronski, L., and Carmella, S. G. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers. Cancer Epidemiol., Biomarkers Prev., 4: 877-884, 1995.
6. 6-methylguanine formation, and metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Cancer Res., 49: 2894-2897, 1989.
7. Morse, M. A., Eklind, K. I., Amin, S. G., Hecht, S. S., and Chung, F-L. Effects of alkyl cbain length on tbe inhibition of NNK-induced lung neoplasia in A/J mice by arylalkyl isothiocyanates. Carcinogenesis (Lond.), 10: 1757-1759, 1989.
8. Morse, M. A., Eklind, K. I., Amin, A. G., and Chung, F-L. Effect of frequency of isothiocyanate administration on inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary adenoma formation in A/J mice. Cancer Lett., 62: 7-81, 1992.
9. El-Bayoumy, K., Upadhyaya, P., Desai, D. H., Amin, S., Hoffmann, D., and Wynder, E. L. Effects of 1,4-phenylenebis(methylene)selenocyanate, phenethyl isothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung. Anticancer Res., 16: 2709-2712, 1996.
10. Morse, M. A., Wang, C-X., Stoner, G. D., Mandal, S., Conran, P. B., Amin, S. G., Hecht, S. S., and Chung, F-L. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl- 1 -butanone-induced DNA adduct formation and tumorigenicity in lung of F344 rats by dietary phenethyl isothiocyanate. Cancer Res., 49: 549-553, 1989.
11. Chung, F-L.. Kelloff, G., Steele, V., Pittman, B., Zang, E., Jiao, D., Rigotty, J., Choi, C-I., and Rivenson, A. Chemopreventive efficacy of arylalkyl isothiocyanates and N-acetylcysteine for lung tumorigenesis in Fischer rats. Cancer Res., 56: 772-778, 1996.
12. Hecht, S. S., Trushin, N., Rigotty, J., Carmella, S. G., Borukhova, A., Akerkar, S. A., and Rivenson, A. Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol., Biomarkers Prev., 5: 645-652, 1996.
13. Stoner, G. D., Morrissey, D., Heur, Y-H., Daniel, E., Galati, A., and Wagner, S. A. Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res., 51: 2063-2068, 1991.
14. Wilkinson, J. T., Morse, M. A., Kresty, L. A., and Stoner, G. D. Effect of alkyl chain length on inhibition of N-nitrosomethylbenzylamine-induced esophageal tumorigenesis and DNA methylation by isothiocyanates. Carcinogenesis (Lond.), 16: 1011-1015, 1995.
15. Stoner, G. D., Adams, C., Kresty, L. A., Hecht, S. S., Murphy, S. E., and Morse, M. A. Inhibition of N′-nitrosonornicotine-induced esophageal tumorigenesis by 3-phenylpropyl isothiocyanate. Carcinogenesis (Lond.), 19: 2139-2143, 1998.
16. National Cancer Institute. Clinical development plan: phenethyl isothiocyanate. J. Cell. Biochem., 265: 149-157, 1996.
17. Hecht, S. S. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ. Health Perspect., 105 (Suppl. 4): 955-963, 1997.
18. Smith, T. J., Guo, Z. Y., Thomas, P. E., Chung, F. L., Morse, M. A., Elkind, K., and Yang, C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Cancer Res., 50: 6817-6822, 1990.
19. Guo, Z., Smith, T. J., Wang, E., Eklind, K. I., Chung, F-L., and Yang, C. S. Structure-activity relationships of arylalkyl isothiocyanates for the inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolism and the modulation of xenobiotic-metabolizing enzymes in rats and mice. Carcinogenesis (Lond.), 14: 1167-1173, 1993.
20. Yang, C. S., Smith, T. J., and Hong, J-Y. Cytochrome P-450 enzymes as targets for chemoprevention against chemical Carcinogenesis and toxicity: opportunities and limitations. Cancer Res., 54 (Suppl.): 1982s-1986s, 1994.
21. Staretz, M. E., and Hecht, S. S. Effects of phenethyl isothiocyanate on the tissue distribution of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and metabolites in F344 rats. Cancer Res., 55: 5580-5588, 1995.
22. Staretz, M. E., Foiles, P. G., Miglietta. L. M., and Hecht, S. S. Evidence for an important role of DNA pyridyloxobutylation in rat lung Carcinogenesis by 4-(methylnitrosamino)-1(3-pyridyl)-1-butanone: effects of dose and phenethyl isothiocyanate. Cancer Res., 57: 259-266, 1997.
23. Staretz, M. E., Koenig, L., and Hecht, S. S. Effects of long term phenethyl isothiocyanate treatment on microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Carcinogenesis (Lond.), 18: 1715-1722, 1997.
24. Hecht, S. S. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem. Res. Toxicol., 11: 559-560, 1998.
25. Gopalakrishnan, R., Morse, M. A., Lu, J., Weghorst, C. M., Sabourin, C. L. K., Stoner, G. D., and Murphy, S. E. Expression of cytochrome P450 2A3 in rat esophagus. Carcinogenesis (Lond.), 20: 885-891, 1999.
26. Benowitz, N. L., Jacob, P., Fong, I., and Gupta, S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J. Pharmacol. Exp. Ther., 268: 296-303, 1994.
27. Byrd, G. D., Chang, K. M., Greene, J. M. and deBethizy, J. D. Evidence for urinary excretion of glucuronide conjugates of nicotine, cotinine, and trans-3′-hydroxycotinine in smokers. Drug Metab. Dispos., 20: 192-197, 1992.
28. Nakajima, M., Yamamoto, T., Nunoya, K-I., Yokoi. T., Nagashima, K., Inoue, K., Funae, Y., Shimada, N., Kamataki, T., and Kuroiwa, Y. Role of human cytcchrome P450 2A6 in C-oxidation of nicotine. Drug Metab. Dispos., 24: 1212-1217, 1996.
29. Messina, E. S., Tyndale, R. F., and Sellers, E. M. A major role for CYP2A6 in nicotine C-oxidation by human liver enzymes. J. Phannacol. Exp. Ther., 282: 1603-1614, 1997.
30. Nakajima, M., Yamamoto, T., Nunoya, K-I., Yokoi, T., Nagashima, K., Inoue, K., Funae, Y., Shimada, N., Kamataki, T., and Kuroiwa, Y. Characteriza-tion of CYP2A6 involved in trans- 3'-hydroxylation of cotinine in human liver microsomes. J. Pharmacol. Exp. Ther., 277: 1010-1015, 1996.
31. Murphy, S. E., Johnson, L. M., and Pullo, D A. Characterization of multiple products of cytochrome P450 2A6 catalyzed cotinine metabolism. Chem. Res. Toxicol., 12: 639-645, 1999.
32. Hecht, S. S., Hatsukami, D. K., Bonilla, L. E., and Hochalter, J. B. Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl)butanoic acid in human urine: a substantial pathway of nicotine metabolism. Chem. Res. Toxicol., 12: 172-179, 1999.
33. Smith, T. J., Guo, Z., Guengerich, F. P., and Yang, C. S. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Carcinogenesis (Lond.), 17: 809-813, 1996.
34. Chen, L., Mohr, S. N., and Yang, C. S. Decrease of plasma and urinary oxidative metabolites of acetaminophen after consumption of watercress by human volunteers. Clin. Pharmacol. Ther., 60: 651-660, 1996.
35. Leclercq, I., Desager, J-P., and Horsmans, Y. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress. Clin. Pharmacol. Ther., 64: 144-149, 1998.
36. Hecht, S. S., Carmella, S. G., Chen, M., Koch, J. F. D., Miller, A. T., Murphy. S. E., Jensen, J. A., Zimmerman, C. L., and Hatsukami, D. K. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res., 59: 590-596, 1999.
37. Jacob, P., III, Shulgin, A. T., Yu, L., and Benowitz, N. L. Determination of the nicotine metabolite trans-3′-hydroxycotinine in urine of smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. J. Chromatogr. Biomed. Appl. 583: 145-154, 1992.
38. Guo, Z., Smith, T. J., Wang, E., Sadrieh, N., Ma, Q., Thomas, P. E., and Yang, C. S. Effects of phenethyl isothiocyanate, a carcinogenesis inhibitor, on xenobiotic-metabolizing enzymes and nitrosamine metabolism in rats. Carcinogenesis (Lond.), 13: 2205-2210, 1992.
39. Hecht, S. S., Spratt, T. E., and Trushin, N. Absolute configuration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) formed metabolically from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis (Lond.), 18: 1851-1854, 1997.
40. Carmella, S. G., Ye, M., Upadhyaya, P., and Hecht, S. S. Analysis of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) enantiomers and NNAL-glucuronide (NNAL-Gluc) diastereomers in smokers' urine. Proc. Am. Assoc. Cancer Res., 40: 250, 1999.
41. Pantuck, E. J., Pantuck, C. B., Anderson, K. E., Wattenberg, L. W., Conney, A. H., and Kappas, A. Effects of brussels sprouts and cabbage on drug conjugation. Clin. Pharmacol. Ther., 35: 161-169, 1984.
42. Schertzer, H. G., and Sainsbury, M. Intrinsic acute toxicity and hepatic enzyme inducing properties of the chemoprotectants indole-3-carbinol and 5,10-dihydroindeno[1:2-b]indole in mice. Food Chem. Toxicol., 29: 237-242, 1991.
43. Schertzer, H. G., and Sainsbury, M. Chemoprotective and hepatic enzyme induction properties of indole and indenoindole antioxidants in rats. Food Chem. Toxicol., 29: 391-400, 1991.
44. Dwivedi, C., Heck, W. J., Downie, A. A., Larroya, S., and Webb, T. E. Effect of calcium glucarate on β-glucuronidase activity and glucarate content of certain fruits and vegetables. Biochem. Med. Metab. Biol., 43: 83-92, 1990.
45. McKennis, H., Schwartz, S. L., Turnbull, L. B., Tamaki, H., and Bowman, E. R. The metabolic formation of γ-(3-pyridyl)-γ-hydroxybutyric acid and its possible intermediary role in the mammalian metabolism of nicotine. J. Biol. Chem., 239: 3981-3989, 1964.
46. Schwartz, S. L., and McKennis, H., Jr. Mammalian degradation of (-)-demethylcotinine. Nature (Lond.), 202: 594-595, 1964.
47. Schwartz, S. L., and McKennis, H., Jr. Studies on the degradation of the pyrrolidine ring of (-)-nicotine in vivo. Formation of γ-(3-pyridyl)-γ-oxobutyric acid. J. Biol. Chem., 238: 1807-1812, 1963.